Disparities in STEMI Management for the Young Goose and Young Gander: Clinical, Organizational, and Educational Challenges
Traditionally women with coronary heart disease (CHD) have been understudied, under recognized, and undertreated, with consequent more adverse outcomes than men1-3. Sex-based differences in CHD outcomes are a compelling basis for enhancing the representation of women in CHD clinical trials. A robust literature specifically identifies that younger women have more adverse outcomes with myocardial infarction and coronary artery bypass graft surgery than do their male peers4.
- Received March 9, 2015.
- Revision received March 12, 2015.
- Accepted March 12, 2015.